ProfileGDS5822 / ILMN_1235278
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 76% 78% 79% 74% 75% 75% 79% 77% 77% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 186.476
GSM1276600PDAC Late Ablation Control 2120.678
GSM1276601PDAC Late Ablation Control 3170.179
GSM1276602PDAC Late Ablation 176.174
GSM1276603PDAC Late Ablation 294.975
GSM1276604PDAC Late Ablation 397.575
GSM1303940PDAC Late Ablation_anti-CTLA4 1114.279
GSM1303941PDAC Late Ablation_anti-CTLA4 2133.877
GSM1303942PDAC Late Ablation_anti-CTLA4 3135.477